{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:57:27Z","timestamp":1794938247884,"version":"4.9.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Korean government","award":["2021R1G1A1006024"],"award-info":[{"award-number":["2021R1G1A1006024"]}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HR21C0198"],"award-info":[{"award-number":["HR21C0198"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Hypothesis<\/jats:title>\n                    <jats:p>Pregnant women with schizophrenia are more likely to discontinue treatment, which could trigger a relapse of symptoms. However, data on patterns and risk factors related to antipsychotic discontinuation and re-initiation in Asian pregnant women are insufficient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using a nationwide Korean database. The pregnancy group included women who had received antipsychotics before pregnancy and was matched 1:2 with a non-pregnancy group. Using Kaplan\u2013Meier curves, we assessed discontinuation patterns during pregnancy and re-initiation patterns among those who discontinued treatment within the first trimester. A Cox proportional hazards regression analysis was used to examine factors associated with first-trimester discontinuation and re-initiation among those who discontinued during this period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>Pregnant women (n\u2005=\u20052066) had a significantly higher risk of discontinuation than did non-pregnant women (adjusted hazard ratio 3.09; 95% confidence interval 2.85\u20133.34). Within the first trimester, 67.5% of pregnant women (n\u2005=\u20051394) discontinued antipsychotic use. Women aged 25\u201329 years were more likely to discontinue (1.25; 1.07\u20131.47). Among first-trimester discontinuers, 35.2% (n\u2005=\u2005491) re-initiated treatment before delivery. A longer duration of antipsychotic use (1.60; 1.06\u20132.42) and higher daily doses (2.47; 1.76\u20133.45) were associated with re-initiation of antipsychotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We revealed that most pregnant women discontinued schizophrenia treatment, but those using higher cumulative doses had a higher likelihood of re-initiation. Our findings imply that treatment decisions for pregnant women should consider various clinical factors, including the history of prescriptions and obstetric characteristics. Moreover, these patients require close monitoring after discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbaf077","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:14:19Z","timestamp":1745568859000},"source":"Crossref","is-referenced-by-count":3,"title":["Antipsychotic Discontinuation and Re-initiation in Pregnant Women With Schizophrenia: A Retrospective Cohort Study From South Korea"],"prefix":"10.1093","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6077-6125","authenticated-orcid":false,"given":"Jiyeon","family":"Kim","sequence":"first","affiliation":[{"name":"College of Pharmacy, Chungnam National University , Daejeon 34134 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kaminska","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University , Daejeon 34134 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Jee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine , Seoul 05505 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6555-9110","authenticated-orcid":false,"given":"Sung Woo","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine , Seoul 05505 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-8829","authenticated-orcid":false,"given":"Bo Ram","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University , Daejeon 34134 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"2026032106212026300_CIT0001","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"2026032106212026300_CIT0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol Rev."},{"key":"2026032106212026300_CIT0003","doi-asserted-by":"crossref","first-page":"916198","DOI":"10.1155\/2012\/916198","article-title":"Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr Res Treatment"},{"key":"2026032106212026300_CIT0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41537-020-0102-z","article-title":"The clinical course of schizophrenia in women and men\u2014a nation-wide cohort study","volume":"6","author":"Sommer","year":"2020","journal-title":"NPJ Schizophr."},{"key":"2026032106212026300_CIT0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","article-title":"Association of in utero antipsychotic medication exposure with risk of congenital malformations in Nordic countries and the US","volume":"80","author":"Huybrechts","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2026032106212026300_CIT0006","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YCO.0000000000000699","article-title":"Estrogens in schizophrenia: progress, current challenges and opportunities","volume":"34","author":"Brand","year":"2021","journal-title":"Curr Opin Psychiatry."},{"key":"2026032106212026300_CIT0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol."},{"key":"2026032106212026300_CIT0008","doi-asserted-by":"crossref","first-page":"e0132280","DOI":"10.1371\/journal.pone.0132280","article-title":"Risk of fetal death after treatment with antipsychotic medications during pregnancy","volume":"10","author":"S\u00f8rensen","year":"2015","journal-title":"PLoS One."},{"key":"2026032106212026300_CIT0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","article-title":"Use and safety of antipsychotic drugs during pregnancy","volume":"15","author":"Einarson","year":"2009","journal-title":"J Psychiatr Pract."},{"key":"2026032106212026300_CIT0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4088\/JCP.15r10483","article-title":"A systematized review of atypical antipsychotics in pregnant women balancing between risks of untreated illness and risks of drug-related adverse effects","volume":"78","author":"Tosato","year":"2017","journal-title":"J Clin Psychiatry."},{"key":"2026032106212026300_CIT0011","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/TCRM.S70545","article-title":"Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report","volume":"10","author":"Ifteni","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"2026032106212026300_CIT0012","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2174\/1570159X22666240516151449","article-title":"Is antipsychotic drug use during pregnancy associated with increased malformation rates and worsening of maternal and infant outcomes? A systematic review","volume":"22","author":"Sani","year":"2024","journal-title":"Curr Neuropharmacol."},{"key":"2026032106212026300_CIT0013","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","article-title":"Antipsychotic medication use among publicly insured pregnant women in the United States","volume":"68","author":"Park","year":"2017","journal-title":"Psychiatr Serv"},{"key":"2026032106212026300_CIT0014","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2014.07.034","article-title":"Discontinuation of antipsychotic medication in pregnancy: a cohort study","volume":"159","author":"Petersen","year":"2014","journal-title":"Schizophr Res."},{"key":"2026032106212026300_CIT0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11126-022-10012-9","article-title":"The patterns of antipsychotic use for pregnant women over a 16-year timeframe in an Australian principal referral and specialist women and newborn hospital","volume":"94","author":"Teoh","year":"2023","journal-title":"Psychiatr Q."},{"key":"2026032106212026300_CIT0016","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00406-022-01453-1","article-title":"Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study","volume":"273","author":"Law","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"2026032106212026300_CIT0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5234\/cnpt.11.61","article-title":"Relapse of psychiatric symptoms after discontinuation of antipsychotics in pregnant women with schizophrenia: a retrospective study","volume":"11","author":"Seki","year":"2020","journal-title":"Clin Neuropsychopharmacol Therapeutics"},{"key":"2026032106212026300_CIT0018","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s10995-013-1419-2","article-title":"Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort","volume":"18","author":"Margulis","year":"2014","journal-title":"Matern Child Health J."},{"key":"2026032106212026300_CIT0019","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review and Assessment (HIRA) Database for Research","volume":"11","author":"Kyoung","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"2026032106212026300_CIT0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2026032106212026300_CIT0021","volume-title":"Korean Medication Algorithm Project for Schizophrenia 2019","author":"Korean College of Neuropsychopharmacology, Korean Society for Schizophrenia Research","year":"2019"},{"key":"2026032106212026300_CIT0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4078\/jrd.2021.28.3.119","article-title":"Clinical study using healthcare claims database","volume":"28","author":"Park","year":"2021","journal-title":"J Rheum Dis."},{"key":"2026032106212026300_CIT0023","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s12888-022-04292-5","article-title":"Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide, health insurance data-based study","volume":"22","author":"Joo","year":"2022","journal-title":"BMC Psychiatry"},{"key":"2026032106212026300_CIT0024","author":"WHO","year":"2024"},{"key":"2026032106212026300_CIT0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am J Psychiatry."},{"key":"2026032106212026300_CIT0026","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol."},{"key":"2026032106212026300_CIT0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12884-022-04452-1","article-title":"Psychiatric vulnerability and the risk for unintended pregnancies, a systematic review and meta-analysis","volume":"22","author":"Schonewille","year":"2022","journal-title":"BMC Pregn Childbirth"},{"key":"2026032106212026300_CIT0028","doi-asserted-by":"crossref","first-page":"e0119939","DOI":"10.1371\/journal.pone.0119939","article-title":"The differences in health care utilization between medical aid and health insurance: a longitudinal study using propensity score matching","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One."},{"key":"2026032106212026300_CIT0029","doi-asserted-by":"crossref","first-page":"114047","DOI":"10.1016\/j.bbr.2022.114047","article-title":"Low income and schizophrenia risk: a narrative review","volume":"435","author":"Schneider","year":"2022","journal-title":"Behav Brain Res."},{"key":"2026032106212026300_CIT0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.mlr.0000254574.23418.f6","article-title":"Adherence to antidepressant treatment among privately insured patients diagnosed with depression","volume":"45","author":"Akincigil","year":"2007","journal-title":"Med Care."},{"key":"2026032106212026300_CIT0031","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0447.2012.01835.x","article-title":"Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment","volume":"125","author":"Langle","year":"2012","journal-title":"Acta Psychiatr Scand."},{"key":"2026032106212026300_CIT0032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/schbul\/sbac138","article-title":"Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. a meta-analysis of randomized controlled trials","volume":"49","author":"Bogers","year":"2023","journal-title":"Schizophr Bull."},{"key":"2026032106212026300_CIT0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-014-0341-5","article-title":"Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy","volume":"14","author":"Fisher","year":"2014","journal-title":"BMC Psychiatry"},{"key":"2026032106212026300_CIT0034","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.psc.2012.06.007","article-title":"Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice","volume":"35","author":"Correll","year":"2012","journal-title":"Psychiatr Clin North Am."},{"key":"2026032106212026300_CIT0035","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.4088\/JCP.20ac13597","article-title":"Long-acting injectable antipsychotic use during pregnancy: a brief review and concise guide for clinicians","volume":"81","author":"Reinstein","year":"2020","journal-title":"J Clin Psychiatry."},{"key":"2026032106212026300_CIT0036","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpsychires.2018.06.019","article-title":"Predictors of severe relapse in pregnant women with psychotic or bipolar disorders","volume":"104","author":"Taylor","year":"2018","journal-title":"J Psychiatr Res."},{"key":"2026032106212026300_CIT0037","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41398-023-02640-x","article-title":"Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset","volume":"13","author":"Misdrahi","year":"2023","journal-title":"Transl Psychiatry."},{"key":"2026032106212026300_CIT0038","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/eip.13143","article-title":"Exploring the clinical relevance of a dichotomy between affective and non-affective psychosis: results from a first-episode psychosis cohort study","volume":"16","author":"Ramain","year":"2022","journal-title":"Early Interv Psychiatry"},{"key":"2026032106212026300_CIT0039","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/da.22352","article-title":"Patterns and factors associated with low adherence to psychotropic medications during pregnancy--a cross-sectional, multinational web-based study","volume":"32","author":"Lupattelli","year":"2015","journal-title":"Depress Anxiety."},{"key":"2026032106212026300_CIT0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1668117","article-title":"Multiple pregnancy: epidemiology and association with maternal and perinatal morbidity","volume":"40","author":"Santana","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2026032106212026300_CIT0041","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/aogs.14579","article-title":"Twins vs singletons\u2014Long-term health outcomes","volume":"102","author":"Wainstock","year":"2023","journal-title":"Acta Obstet Gynecol Scand."},{"key":"2026032106212026300_CIT0042","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.4088\/JCP.16m11308","article-title":"Does half-life matter after antipsychotic discontinuation? A relapse comparison in schizophrenia with 3 different formulations of paliperidone","volume":"78","author":"Weiden","year":"2017","journal-title":"J Clin Psychiatry."},{"key":"2026032106212026300_CIT0043","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/03007995.2016.1266313","article-title":"Association between use of short-acting benzodiazepines and migraine occurrence: a nationwide population-based case-control study","volume":"33","author":"Harnod","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"2026032106212026300_CIT0044","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"2026032106212026300_CIT0045","doi-asserted-by":"crossref","first-page":"104257","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol Dis."},{"key":"2026032106212026300_CIT0046","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ph14030238","article-title":"Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences","volume":"14","author":"Carli","year":"2021","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbaf077\/63389911\/sbaf077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/2\/sbaf077\/63389911\/sbaf077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T10:21:34Z","timestamp":1774088494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbaf077\/8151993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5,28]]},"published-print":{"date-parts":[[2026,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaf077","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,5,28]]},"article-number":"sbaf077"}}